Изображения страниц
PDF
EPUB

ABUSE OF DANGEROUS LICIT AND ILLICIT DRUGS PSYCHOTROPICS, PHENCYCLIDINE (PCP), AND TALWIN

[blocks in formation]

SELECT COMMITTEE ON
NARCOTICS ABUSE AND CONTROL
HOUSE OF REPRESENTATIVES

NINETY-FIFTH CONGRESS

SECOND SESSION

AUGUST 8, 10, SEPTEMBER 19, AND OCTOBER 6, 1978

[merged small][merged small][ocr errors]
[graphic][ocr errors]

4

United States, lougeas, douse, Select Committee
"Narcotics Abuse and Control,
ABUSE OF DANGEROUS LICIT AND ILLICIT DRUGS-
PSYCHOTROPICS, PHENCYCLIDINE (PCP), AND TALWIN

[ocr errors]

HEARINGS

BEFORE THE

SELECT COMMITTEE ON
NARCOTICS ABUSE AND CONTROL
HOUSE OF REPRESENTATIVES

NINETY-FIFTH CONGRESS

SECOND SESSION

AUGUST 8, 10, SEPTEMBER 19, AND OCTOBER 6, 1978

Printed for the use of the
Select Committee on Narcotics Abuse and Control

SCNAC-95–2–22

U.S. GOVERNMENT PRINTING OFFICE

38-999 O

WASHINGTON : 1979

:N3

1978 e

SELECT COMMITTEE ON NARCOTICS ABUSE AND CONTROL

LESTER L. WOLFF, New York, Chairman PETER W. RODINO, JR., New Jersey

J. HERBERT BURKE, Florida PAUL G. ROGERS, Florida

TOM RAILSBACK, Illinois E (KIKA) DE LA GARZA, Texas

LOUIS FREY, JR., Florida JAMES R. MANN, South Carolina

ROBIN L, BEARD, Tennessee MORGAN F. MURPHY, Illinois

BENJAMIN A. GILMAN, New York CHARLES B. RANGEL, New York

TENNYSON GUYER, Ohio
FORTNEY H. (PETE) STARK, California
GLENN ENGLISH, Oklahoma
BILLY L. EVANS, Georgia
LDO C. ZEFERETTI, New York
DANIEL K. AKAKA, Hawaii

Ex Oficio
MARIO BIAGGI, New York

CARDISS COLLINS, Illinois
STEPHEN L. NEAL, North Carolina

JOE SKUBITZ, Kansas
DANTE B. FASCELL, Florida
ROBERT K. DORNAN, California

LINDY BOGGS, Louisiana
BARBARA A. MIKULSKI, Maryland
PATRICIA SCHROEDER, Colorado

COMMITTEE STAFF
JOSEPH L. NELLIS, Chief Counsel
WILLIAM G. LAWRENCE, Chief of Staff
DOREEN THOMPSON, Staf Counsel
HOWARD WALLACH, Staff Counsel

TASK FORCE ON ABUSE OF LICIT AND ILLICIT DRUGS

MORGAN F. MURPHY, Illinois, Task Force Chairman PAUL G. ROGERS, Florida

TOM RAILSBACK, Illinois

TASK FORCE STAFF MEMBERS
MICHAEL BACKENHEIMER, Professional Staff Member

ALMA BACHRACH, Investigator

DAN STEIN, Researcher
ROBERT M. ORB, Researcher

(II)

79-603500

[ocr errors][merged small]

Page

1

Tuesday, August 8, 1978..

Testimony of Hon. Norman Y. Mineta, a Representative in Congress

from the State of California.

Testimony of Lee I. Dogoloff, Associate Director, Domestic Policy

Staff, the White House-

Testimony of Peter B. Bensinger, Administrator, Drug Enforcement

Administration; accompanied by James M. Smith, Special Agent,

Los Angeles Regional Office, DEA.

Testimony of Dorynne Czechowicz, M.D., Special Assistant to the

Director of the Division of Community Assistance, and Chairman

of the National Institute on Drug Abuse PCP Task Force; accom-

panied by Dr. Robert C. Petersen, NIDA.

Afternoon session, August 8, 1978.

Testimony of Hon. Lloyd Bentsen, a Senator from the State of Texas.

Testimony of Iola Scrafford, director, crossroads program, Fairfax, Va.;

accompanied by Edward Rugenstein and Steve Rugenstein.

Testimony of Paul Luisada, M.D., psychiatrist and Deputy Medical

Director of the Area D Community Mental Health Center, National

Institute of Mental Health..

Testimony of Frank E. Minyard, M.D., coroner of Orleans Parish,

New Orleans, La..

Testimony of Lt. James Elkins, director of vice/narcotics division,

Montgomery County, Md., Department of Police.---

Submissions for the record:

Letter to Chairman Wolff from Lee I. Dogoloff, dated October 13,

1978...

Letter to Chairman Wolff from William S. Apple, American

Pharmaceutical Association.--

Letter to Chairman Wolff from Lee I. Dogoloff, dated October 17,

1978...

Prepared statements:

Prepared statement of Hon. Norman Y, Mineta.

Prepared statement of Lee I. Dogoloff...

Prepared statement of Peter B. Bensinger-

Prepared statement of Dorynne Czechowicz..

Prepared statement of Senator Lloyd Bentsen.

Prepared statement of Frank E. Minyard.--

Thursday, August 10, 1978.

Testimony of Charles Brannan, former detailman with Hoffmann-

La Roche Inc.

Testimony of Dr. Leonard G. Schifrin, professor of economics, Col-

lege of William and Mary, Williamsburg, Va---
Testimony of Jonathan 0. Cole, M.D., psychopharmacology program,

McLean Hospital, Belmont, Mass.

Afternoon session, August 10, 1978-

Testimony of Irwin Lerner, vice president of marketing, Hoffmann-

La Roche Inc.

Testimony of Ms. Sue Boe, assistant vice president, consumer affairs

of the Pharmaceutical Manufacturers Association; accompanied by

Bruce J. Brennan, vice president and general counsel..

Testimony of Robert F. Maronde, M.D., professor of medicine,

section of chemical pharmacology, University of Southern

California.

84

« ПредыдущаяПродолжить »